314 Views

Small Animal

Session: Updates in Liquid Biopsy: From Cancer Screening to Post-treatment monitoring

S22B - Updates in Liquid Biopsy: From Cancer Screening to Post-treatment Monitoring

Sunday, February 19, 2023

11:00 AM – 11:50 AM

Location: Mandalay Bay L, Level 2

Earn 1 CE Hours

Sponsored By PETDX

PetDX

Presenter(s)

Andi Flory, DVM, DACVIM (Oncology)

Chief Medical Officer
PETDX
Encinitas, CA, United States

Moderator(s)

Jason Chibuk, MS

Co-Founder & Head of Medical Affairs
PetDx
San Diego, California, United States

The clinical validation study of next-generation sequencing-based liquid biopsy testing for multi-cancer detection in dogs was published in 2022. This session will provide and overview of liquid biopsy technology, test performance, and the various applications of this testing in pre- and Post diagnosis use cases. Recent clinical laboratory experience will be reviewed, along with a series of interesting real-world case studies that demonstrate how this testing is being used in clinical practice.

Learning Objectives:

Review the fundamentals of next-generation sequencing-based liquid biopsy testing for multi-cancer detection in dogs
Define the various clinical use cases in which liquid biopsy can be applied
Review up-to-date laboratory experience with liquid biopsy testing